INS and metabolic disease: Furthermore, the activity of the branched-chain α-ketoacid dehydrogenase complex is shown to be reduced in conditions of impaired insulin function, reducing catabolism of BCAA reflected by the characteristic elevation of their circulating levels in individuals with metabolic disease (47, 48).